[
    {
        "example_id": 13,
        "problem": [
            "ChIP-seq on a PFA-fixed sample with an antibody to the IKAROS transcription factor in human B cells followed by next-generation sequencing and standard quality control, alignment and peak-calling steps produced ChIP peaks that disappeared when PFA+DSG fixation was used. Where are we most likely to find such disappearing peaks?",
            "At active promoters and enhancers",
            "At repeats",
            "In the introns of large genes",
            "At random locations in the genome",
            0
        ],
        "correct_answer": 0,
        "n": "abstracted_workflow_0_13",
        "response": "PFA+DSG fixation masks direct IKAROS\u2013DNA binding at sharp sites found at active promoters and enhancers, so peaks there disappear.\n\nAnswer:A)",
        "sub_tasks_text": null
    },
    {
        "example_id": 13,
        "problem": [
            "ChIP-seq on a PFA-fixed sample with an antibody to the IKAROS transcription factor in human B cells followed by next-generation sequencing and standard quality control, alignment and peak-calling steps produced ChIP peaks that disappeared when PFA+DSG fixation was used. Where are we most likely to find such disappearing peaks?",
            "At active promoters and enhancers",
            "At repeats",
            "In the introns of large genes",
            "At random locations in the genome",
            0
        ],
        "correct_answer": 0,
        "n": "abstracted_workflow_5_13",
        "response": "All debate agents agree that dual PFA+DSG fixation abolishes narrow, high-signal TF\u2013DNA crosslinks at active regulatory elements, leading to peak loss at promoters and enhancers.\n\nAnswer:A)",
        "sub_tasks_text": null
    }
]